ARTICLE | Clinical News
Eflornithine difluoromethylornithine regulatory update
October 25, 2010 7:00 AM UTC
The European Commission granted Orphan Drug designation for Cancer Prevention's eflornithine to treat familial adenomatous polyposis (FAP). The ornithine decarboxylase inhibitor is in Phase II testin...